![Ezio Ghigo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ezio Ghigo
Founder at Millendo Therapeutics SAS
Ezio Ghigo active positions
Companies | Position | Start | End |
---|---|---|---|
Millendo Therapeutics SAS
![]() Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Founder | 08/09/2009 | - |
Chief Tech/Sci/R&D Officer | 08/09/2009 | 21/05/2010 | |
University of Turin | Chairman | 08/09/2009 | - |
Career history of Ezio Ghigo
Former positions of Ezio Ghigo
Companies | Position | Start | End |
---|---|---|---|
Pfizer NV/SA | Corporate Officer/Principal | 21/05/2010 | - |
Ipsen NV
![]() Ipsen NV Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Ipsen NV is a Belgian biopharmaceutical company that improves patients' lives through research and innovation in oncology, rare disease, and neuroscience. Founded in 1982, the company is based in Merelbeke, Belgium. Ipsen is a global mid-sized biopharmaceutical company that focuses on improving patients' lives through its research and innovation in the field of oncology, rare diseases, and neuroscience. | Corporate Officer/Principal | - | - |
NOVARTIS AG | Corporate Officer/Principal | - | - |
THERATECHNOLOGIES INC. | Corporate Officer/Principal | - | - |
UCB Pharma GmbH
![]() UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | - | - |
Europeptides GEIE
![]() Europeptides GEIE Miscellaneous Commercial ServicesCommercial Services Europeptides GEIE is a French pharmaceutical company that specializes in researching and developing products for the reproductive health care sector. The company is based in Argenteuil, France. Europeptides GEIE was acquired by Ardana Plc from E.ON SE on July 11, 2002 for $27.87 million. | Corporate Officer/Principal | - | - |
Pharmacia AB | Corporate Officer/Principal | 21/05/2010 | - |
░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Statistics
International
France | 3 |
Italy | 3 |
Sweden | 3 |
Operational
Corporate Officer/Principal | 9 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 8 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
PIERREL S.P.A. | Health Technology |
NOVARTIS AG | Health Technology |
THERATECHNOLOGIES INC. | Health Technology |
Private companies | 7 |
---|---|
Millendo Therapeutics SAS
![]() Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Health Technology |
Kabivitrum AB | |
Pharmacia AB | Health Technology |
Europeptides GEIE
![]() Europeptides GEIE Miscellaneous Commercial ServicesCommercial Services Europeptides GEIE is a French pharmaceutical company that specializes in researching and developing products for the reproductive health care sector. The company is based in Argenteuil, France. Europeptides GEIE was acquired by Ardana Plc from E.ON SE on July 11, 2002 for $27.87 million. | Commercial Services |
UCB Pharma GmbH
![]() UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
Pfizer NV/SA | |
Ipsen NV
![]() Ipsen NV Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Ipsen NV is a Belgian biopharmaceutical company that improves patients' lives through research and innovation in oncology, rare disease, and neuroscience. Founded in 1982, the company is based in Merelbeke, Belgium. Ipsen is a global mid-sized biopharmaceutical company that focuses on improving patients' lives through its research and innovation in the field of oncology, rare diseases, and neuroscience. | Health Technology |
- Stock Market
- Insiders
- Ezio Ghigo
- Experience